CREST-2 Trial: Carotid Revascularization and Cognition

CREST-2 investigators looked at how carotid stenting and carotid endarterectomy affect cognitive outcomes in patients with asymptomatic carotid stenosis. A JAMA editorial summarizes the takeaway: revascularization may still be justified in some patients, but not as a way to improve cognition. The indication stays what it has always been, which is stroke prevention.

What happened

CREST-2 is a trial of revascularization for asymptomatic carotid artery stenosis. This report addresses a specific question: does opening a narrowed carotid artery, by stenting (CAS) or by surgical endarterectomy (CEA), improve how patients think, remember, and process information?

According to the JAMA editorial, the answer is no. Revascularization does not appear to improve cognitive function. The editorial's message is that the procedure may be reasonable for other reasons, but cognitive benefit should not be one of them.

One caveat about this article: the source material available to us is only a short summary of the JAMA editorial. It does not include sample size, follow-up duration, the cognitive tests used, or effect estimates, so we do not report any of those. Check the full JAMA text if you need the numbers.

Why it matters

The idea that fixing a carotid stenosis might also help the brain is intuitive. If a narrowed internal carotid artery reduces cerebral perfusion or sheds microemboli, then relieving the stenosis could plausibly reverse some cognitive decline. Patients and clinicians have sometimes hoped for exactly this.

The CREST-2 cognitive results, as summarized in the editorial, argue against using cognition as a reason to operate or stent. That matters in practice because both procedures carry risks. These include periprocedural stroke, myocardial infarction, and cranial nerve injury. A procedure justified only by a cognitive benefit that has not been shown would be hard to defend.

It also matters for exam logic. Asymptomatic carotid stenosis is a prevention problem. The question to ask is whether the patient's absolute risk of future ipsilateral stroke is high enough, and the periprocedural risk low enough, to justify intervention on top of medical therapy.

What to know for the USMLE

• Asymptomatic vs symptomatic stenosis. Symptomatic means a recent TIA, amaurosis fugax, or non-disabling stroke in the territory of the affected carotid. Benefit from revascularization is clearest in symptomatic patients with high-grade stenosis (classically 70–99% by NASCET criteria), and surgery is ideally done within about 2 weeks of the event. The CREST-2 population is different: it is asymptomatic.
• Medical therapy is the foundation for everyone. This means antiplatelet therapy (aspirin or clopidogrel), a high-intensity statin, blood pressure control, glycemic control in diabetes, and smoking cessation. Asymptomatic patients are managed this way first.
• CEA vs CAS. In the original CREST trial, stenting had more periprocedural stroke and endarterectomy had more periprocedural myocardial infarction. Older patients tend to do better with CEA. CAS is often favored when anatomy makes surgery hard: prior neck radiation, prior neck surgery, a high carotid bifurcation, or severe cardiac comorbidity.
• Classic CEA complications. Know hyperperfusion syndrome (ipsilateral headache, seizures, or hemorrhage after reperfusion of a chronically hypoperfused hemisphere), cranial nerve injury (hypoglossal causing tongue deviation toward the lesion, recurrent laryngeal causing hoarseness, and marginal mandibular branch of the facial nerve), and neck hematoma.
• Baroreceptor reflex after carotid intervention. Manipulation of the carotid sinus can cause bradycardia and hypotension. Stenting can do this too, because the stent sits at the carotid bulb.
• Diagnosis. Carotid duplex ultrasonography is the usual first test. CT angiography or MR angiography confirms the degree of stenosis and defines anatomy. A carotid bruit alone is a poor predictor of stenosis severity.
• Pathogenesis. Atherosclerotic plaque typically forms at the carotid bifurcation, where low shear stress and turbulent flow promote lipid deposition. Stroke occurs mainly by artery-to-artery embolism from plaque rupture, less often from hemodynamic hypoperfusion. Ocular emboli cause amaurosis fugax, a transient monocular vision loss.
• Stroke-prevention logic. Intervention is considered only when expected benefit exceeds risk. In asymptomatic patients this usually means a high-grade stenosis, a low perioperative complication rate, and a reasonable life expectancy.
• Cognitive link. Vascular cognitive impairment arises from small-vessel disease, strokes, and chronic hypoperfusion. The CREST-2 cognitive report suggests that treating the carotid lesion does not reliably reverse cognitive problems. Do not choose "carotid revascularization to improve memory" as an answer on an exam.

Limitations

Our summary comes from a brief description of a JAMA editorial, not the full trial report. We cannot comment on how large the study was, how long patients were followed, which cognitive tests were used, or whether any subgroup behaved differently.

Some general points apply to any cognitive-outcome analysis. Cognitive function is hard to measure and is influenced by age, education, vascular risk factors, depression, and small-vessel disease that a carotid procedure would not touch. A null result on average does not rule out benefit in a particular person. It also does not show that revascularization is harmful to cognition.

This news does not change the stroke-prevention question. The editorial says revascularization may still be justified, and that justification rests on stroke prevention. This article does not give guidance for any individual patient.

FAQ

Does carotid stenting or endarterectomy improve cognitive function in asymptomatic carotid stenosis?

According to the JAMA editorial on CREST-2, revascularization does not improve cognitive function. The editorial concludes that any justification for the procedure should rest on something else.

Why do doctors still consider revascularization for asymptomatic carotid stenosis?

The purpose is stroke prevention. Intervention is weighed against the risks of the procedure and against medical therapy alone, and the decision depends on the patient's overall situation. Cognitive improvement is not the target.

How should I answer a USMLE question on carotid stenosis management?

Start by deciding whether the patient is symptomatic. For symptomatic high-grade stenosis, think prompt revascularization, usually CEA, plus medical therapy. For asymptomatic stenosis, think aggressive medical therapy first, with intervention only for selected low-risk patients. Know the complications of each procedure.

Key takeaways

• A JAMA editorial on CREST-2 concludes that carotid revascularization does not improve cognitive function in asymptomatic stenosis.
• Revascularization may still be justified, but the indication remains stroke prevention, not cognitive benefit.
• For USMLE, know symptomatic vs asymptomatic management, CEA vs CAS trade-offs, procedural complications, and the role of medical therapy.